Jobs / United States / Novartis Pharmaceuticals Corporation
Value & Access Head BeLux
Novartis Pharmaceuticals Corporation · 🇺🇸 Vilvoorde
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Salary Range: €115,300.00 - €214,100.00 Job Description Summary #LI-Hybrid Location: Brussels, Belgium Relocation Support: Yes Ready to shape the future of healthcare access and help bring innovative medicines to patients faster? As the Value & Access Head BeLux, you will lead the development and execution of integrated access, pricing, health economics and outcomes research, health technology assessment, and healthcare system-shaping strategies. Your leadership will be instrumental in securing timely, equitable, and commercially sustainable patient access to Novartis innovations across the portfolio, with particular focus on priority therapeutic areas and critical launches. Reporting directly to the Country President, you will shape the evolving healthcare ecosystem, build strategic external partnerships, and mobilize cross-functional teams around compelling value propositions for payers, policymakers, healthcare providers, and patients. This is a unique opportunity to lead a high-performing Value & Access organization, influence healthcare outcomes at scale, and create sustainable value for patients, healthcare systems, and Novartis. Job Description Key Responsibilities: • Lead the national Value & Access strategy across priority therapeutic areas and key launches. • Shape pipeline opportunities and maximize asset value by incorporating payer insights and access considerations. • Drive integrated access plans with Commercial, Medical, Public Affairs, Finance, and international partners. • Build strategic partnerships with governments, payers, policymakers, healthcare providers, hospitals, and patient organizations. • Shape healthcare systems through collaborative solutions that improve patient access, affordability, and sustainability. • Define national pricing strategies and lead reimbursement negotiations, tendering, contracting, and pricing governance. • Oversee health economics, health technology assessment, evidence planning, value dossiers, and submission excellence. • Lead Access Field teams and account strategies to accelerate access and strengthen healthcare system readiness. • Drive launch excellence, timely access, sustainable price realization, and successful reimbursement outcomes across the portfolio. • Build and develop a high-performing organization that fosters innovation, collaboration, accountability, and talent progression. Essential Requirements: • Bachelor’s, Master’s, Doctor of Pharmacy, or equivalent degree in a relevant scientific, healthcare, or economic discipline. • Minimum 10 years of experience in Market Access, Pricing, Health Economics, Health Policy, or related disciplines. • Proven people leadership experience, including leading, developing, coaching, and retaining high-performing teams. • Deep understanding of healthcare systems, reimbursement pathways, pricing frameworks, and payer decision-making processes. • Strong track record in pricing strategy, reimbursement negotiations, innovative contracting, and payer strategy development. • Experience engaging governments, payers, health technology assessment agencies, policymakers, providers, and other external stakeholders. • Demonstrated ability to lead across Commercial, Medical, Public Affairs, Finance, and other cross-functional partners. • Strategic leadership capability to navigate complexity, influence senior stakeholders, shape external environments, and deliver sustainable impact. • Proficient English, both written and spoken. Benefits: Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: Novartis Life Handbook Expected Annual Base Salary Range for role: 115,300.00 - 214,100.00 EUR The base salary offered is determined based on gender-neutral objectives, such as